BioLife Solutions, Inc. (BLFS) Social Stream
BIOLIFE SOLUTIONS INC (BLFS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BLFS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 8 | $65 | $54 | $60.571 | $17.23 | 251.54% |
| 2022-03-01 | 8 | $67 | $54 | $61.428 | $17.23 | 256.52% |
| 2022-03-02 | 8 | $67 | $50 | $59.428 | $17.23 | 244.91% |
| 2022-03-16 | 8 | $65 | $48 | $56.714 | $17.23 | 229.16% |
| 2022-04-01 | 7 | $65 | $47 | $54 | $17.23 | 213.41% |
| 2022-04-25 | 7 | $65 | $28 | $49.666 | $17.23 | 188.25% |
| 2022-05-09 | 7 | $65 | $28 | $44.666 | $17.23 | 159.23% |
| 2022-05-11 | 7 | $48 | $28 | $36.666 | $17.23 | 112.8% |
| 2022-05-12 | 6 | $48 | $28 | $35.714 | $17.23 | 107.28% |
| 2022-05-17 | 6 | $47 | $28 | $33.714 | $17.23 | 95.67% |
| 2022-07-15 | 8 | $40 | $28 | $32.714 | $17.23 | 89.87% |
| 2022-08-01 | 8 | $38 | $28 | $32.428 | $17.23 | 88.21% |
| 2022-09-29 | 8 | $38 | $28 | $32 | $17.23 | 85.72% |
| 2022-11-16 | 8 | $35 | $28 | $31.142 | $17.23 | 80.74% |
| 2022-12-01 | 8 | $35 | $28 | $31 | $17.23 | 79.92% |
| 2023-02-24 | 8 | $34 | $28 | $30.571 | $17.23 | 77.43% |
| 2023-03-20 | 7 | $34 | $29.001 | $31 | $17.23 | 79.92% |
| 2023-03-21 | 7 | $34 | $29 | $31 | $17.23 | 79.92% |
| 2023-04-03 | 7 | $33 | $27 | $30.166 | $17.23 | 75.08% |
| 2023-05-15 | 6 | $33 | $27 | $30.166 | $17.23 | 75.08% |
| 2023-06-01 | 5 | $33 | $27 | $30.166 | $17.23 | 75.08% |
| 2023-07-11 | 5 | $32 | $27 | $29.5 | $17.23 | 71.21% |
| 2023-08-01 | 5 | $32 | $29 | $29.833 | $17.23 | 73.15% |
| 2023-08-10 | 7 | $30 | $22 | $25.857 | $17.23 | 50.07% |
| 2023-09-08 | 7 | $30 | $22 | $25.142 | $17.23 | 45.92% |
| 2023-10-23 | 7 | $30 | $20 | $24.428 | $17.23 | 41.78% |
| 2023-11-10 | 7 | $30 | $18 | $23.857 | $17.23 | 38.46% |
| 2023-11-13 | 7 | $30 | $15 | $22.142 | $17.23 | 28.51% |
| 2023-12-01 | 8 | $30 | $15 | $22.142 | $17.23 | 28.51% |
The Trend in the Analyst Price Target
Over the past 13 months, BLFS's average price target has gone down $9.
Over the past 46 weeks, BLFS's average upside potential has been 62.07%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-11 | 6 | 33 | 27 | 30.166 | 18.25 | 65.29% |
| 2023-05-15 | 6 | 33 | 27 | 30.166 | 19.46 | 55.02% |
| 2023-06-01 | 5 | 32 | 27 | 29.600 | 23.10 | 28.14% |
| 2023-11-10 | 7 | 30 | 18 | 23.857 | 10.95 | 117.87% |
| 2023-12-01 | 8 | 30 | 15 | 22.142 | 13.25 | 67.11% |
BLFS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 31 weeks, BLFS's average broker recommendation rating worsened by 0.25.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, BIOLIFE SOLUTIONS INC's upside potential (average analyst target price relative to current price) is greater than 2624.99% of them.
- To contextualize these metrics, consider that out of all US stocks, BIOLIFE SOLUTIONS INC's variance in analysts' estimates is lower than -1148.43% of them.
- BIOLIFE SOLUTIONS INC's average analyst price target is higher than 1366.45% of Medical Equipment stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, BIOLIFE SOLUTIONS INC's number of analysts covering the stock is greater than 1434.86% of them.
In the Medical Equipment industry, OM, SILK, and INO are the three stocks most similar to BIOLIFE SOLUTIONS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BLFS? Use POWR Ratings for clearer insight into price direction.